Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 07:52 am Sale |
2024-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
STATE STREET CORP STT |
1,326,158 4.900% |
-303,508 (-18.62%) |
Filing History |
| 2024-11-08 3:17 pm Purchase |
2024-09-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
Nikko Asset Management Americas, Inc. | 2,315,294 8.560% |
994,642 (+75.31%) |
Filing History |
| 2024-11-05 06:07 am Purchase |
2024-09-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
Sumitomo Mitsui Trust Group, Inc. | 2,315,294 8.560% |
994,642 (+75.31%) |
Filing History |
| 2024-04-05 12:18 pm Purchase |
2024-03-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
BLACKROCK INC BLK |
2,743,002 10.200% |
344,706 (+14.37%) |
Filing History |
| 2024-02-13 4:59 pm Purchase |
2023-12-29 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
The Vanguard Group | 1,458,380 5.460% |
7,955 (+0.55%) |
Filing History |
| 2024-02-12 6:09 pm Sale |
2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
Nikko Asset Management Americas, Inc. | 1,320,652 4.940% |
-128,408 (-8.86%) |
Filing History |
| 2024-02-05 06:08 am Sale |
2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
Sumitomo Mitsui Trust Group, Inc. | 1,320,652 4.940% |
-128,408 (-8.86%) |
Filing History |
| 2024-01-29 4:01 pm Purchase |
2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
ARK Investment Management LLC | 2,047,687 7.660% |
35,258 (+1.75%) |
Filing History |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
BLACKROCK INC BLK |
2,398,296 9.000% |
513,411 (+27.24%) |
Filing History |
| 2024-01-25 07:48 am Sale |
2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
STATE STREET CORP STT |
1,629,666 6.100% |
-38,259 (-2.29%) |
Filing History |
| 2024-01-17 2:43 pm Purchase |
2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
FEDERATED HERMES INC. FHI |
4,711,512 17.630% |
471,958 (+11.13%) |
Filing History |
| 2023-10-10 11:20 am Sale |
2023-09-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
STATE STREET CORP STT |
1,667,925 6.270% |
-589,921 (-26.13%) |
Filing History |
| 2023-02-10 10:48 am Sale |
2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
ARK Investment Management LLC | 2,012,429 7.580% |
-460,201 (-18.61%) |
Filing History |
| 2023-02-10 10:29 am Purchase |
2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
Nikko Asset Management Americas, Inc. | 1,449,060 5.450% |
91,588 (+6.75%) |
Filing History |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
The Vanguard Group | 1,450,425 5.460% |
1,450,425 (New Position) |
Filing History |
| 2023-02-08 09:52 am Sale |
2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
STATE STREET CORP STT |
2,257,846 8.500% |
-960,111 (-29.84%) |
Filing History |
| 2023-02-03 06:10 am Purchase |
2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
Sumitomo Mitsui Trust Group, Inc. | 1,449,060 5.450% |
91,588 (+6.75%) |
Filing History |
| 2023-02-01 10:11 am Purchase |
2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
FEDERATED HERMES INC. FHI |
4,239,554 16.000% |
544,625 (+14.74%) |
Filing History |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
BLACKROCK INC BLK |
1,884,885 7.100% |
125,295 (+7.12%) |
Filing History |
| 2022-04-11 1:47 pm Purchase |
2022-03-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
STATE STREET CORP STT |
3,217,957 12.200% |
1,161,883 (+56.51%) |
Filing History |